imdevimab   Click here for help

GtoPdb Ligand ID: 11328

Synonyms: REGN-10987 | REGN10987 | Ronapreve® (imdevimab + casirivimab)
Approved drug
imdevimab is an approved drug (Japan and UK MHRA (2021))
Compound class: Antibody
Comment: Imdevimab is a fully human monoclonal antibody against the surface spike protein of SARS-CoV-2 [1-2]. It is a virus neutralising mAb that was developed by Regeneron.
Click here for help
Classification Click here for help
Compound class Antibody
Approved drug? Yes (Japan and UK MHRA (2021))
International Nonproprietary Names Click here for help
INN number INN
11863 imdevimab
Synonyms Click here for help
REGN-10987 | REGN10987 | Ronapreve® (imdevimab + casirivimab)
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1108
Other databases
GtoPdb PubChem SID 434321763
Search PubMed clinical trials imdevimab
Search PubMed titles imdevimab
Search PubMed titles/abstracts imdevimab